You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆汇港股聚焦(05.17)︱同程艺龙一季度经调整纯利大增279.5%;康哲药业收购一家医疗美容聚焦超声技术平台公司
格隆汇 05-17 23:31

【分拆上市】

中集集团(02039.HK):董事会同意中集安瑞环科拟于深交所发行A股并上市

【财务数据】

同程艺龙(00780.HK)一季度经调整纯利大增279.5% 总交易额升83%至333亿元

亿胜生物科技(01061.HK)前4个月收益约4.38亿港元 同比增长242.2%

【业绩预告】

震雄集团(00057.HK)预计年度纯利增长逾110%

创升控股(02680.HK)年度纯利预增不少于40%

FAIRWOOD HOLD(00052.HK)年度预盈1.5亿港元

KFM金德(03816.HK)预期2021财年纯利约1900万港元

【运营数据】

齐屹科技(01739.HK):一季度SaaS及延伸服务业务收入同比增加75%

【增减持】

时代邻里(09928.HK)获控股股东卓源增持90万股

【股权变更】

红星美凯龙(01528.HK)控股股东拟将不超1800万股公司股份转让给其一致行动人西藏奕盈

【并购出售】

康哲药业(00867.HK)拟收购一家医疗美容聚焦超声技术平台公司

宝业集团(02355.HK)拟2.03亿元收购武汉裕筑房地产开发剩余51%股权

新丰泰集团(01771.HK)拟1.5亿元出售西安秦睿置业25%股权

上海实业环境(00807.HK)附属拟收购河南闻诺80%股权 上实环境武汉注册股本增至4.66亿元

金茂源环保(06805.HK)竞得四川青神县一地块使用权

【投资运营】

德琪医药-B(06996.HK)与Calithera达成CD73抑制剂CB-708 (ATG-037)开发和商业化的全球独家授权协议

云顶新耀-B(01952.HK):国家药品监督管理局受理创新药戈沙妥组单抗治疗转移性三阴性乳腺癌生物制品上市许可申请

中国交通建设(01800.HK)成立项目公司以共同投资洪湖市施墩河湖中心河片区综合治理PPP项目

阜博集团(03738.HK)拟为新传在线提供版权保护和内容管理变现服务

旅橙文化(08627.HK)拟成立业务公司 从事媒体制作业务

荣昌生物-B(09995.HK):H股全流通获联交所授出上市批准

华记环球集团(02296.HK)旗下华记环球设计年初至今已落实超30个设计项目

康希诺生物-B(06185.HK):上药康希诺注册资本将增加至12.05亿元

亿都(国际控股)(00259.HK):南通江海及苏州金龙共同开发的首台锂离子超级电容器纯电动客车已成功推出

中州证券(01375.HK):获得政府补助合计1224.21万元

【回购注销】

日清食品(01475.HK)5月17日耗资898万港元回购147万股

海尔智家(06690.HK)5月17日回购118.36万股H股及5万股A股

中国旺旺(00151.HK)5月17日耗资162.71万港元回购28.2万股

【股权激励】

怡园酒业(08146.HK)授出1000万份购股权

蓝港互动(08267.HK)授出合共364.5万份购股权

都市丽人(02298.HK):受托人就股份奖励计划购买50万股

美高梅中国(02282.HK)授出29万份购股权

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account